Conference Proceedings

IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC with Atezolizumab plus Chemotherapy

N Rizvi, D Gandara, B Solomon, A Kim, A Brunelli, S Sun, B Gitlitz, K Tajima, W Lin, A Sandler, S Peters

JOURNAL OF THORACIC ONCOLOGY | ELSEVIER SCIENCE INC | Published : 2018

DOI: 10.1016/j.jtho.2018.08.1553

University of Melbourne Researchers

Citation metrics

7Web of Science
7Dimensions

Keywords

Respiratory System
3211 Oncology and Carcinogenesis
6.1 Pharmaceuticals
Neoadjuvant
Oncology
Atezolizumab
Life Sciences & Biomedicine
Science & Technology
Nsclc
32 Biomedical and Clinical Sciences
Cancer